期刊文献+

乳化挥散法制备多西他赛脂质体 被引量:1

Preparation of liposomes containing docetaxel by emulsifying-volatilizing method
在线阅读 下载PDF
导出
摘要 目的制备抗肿瘤药物多西他赛脂质体,为下一步进行动物实验和临床研究奠定基础。方法采用乳化挥散法制备多西他赛脂质体,优化处方中大豆磷脂-鱼油乙酯-胆固醇硫酸钠-多西他赛(SPC-EPA-SCS-DOC)物质的量比为7∶1.8∶1.2∶1,并对其理化性质进行了考察。结果制备的多西他赛脂质体形态理想,粒径分布均匀,平均直径约(110±10)nm,包封率为95%以上,符合静脉给药的要求。结论该方法制备多西他赛脂质体简便易行,方法可靠。 Objective To optimize the formulation of liposomes containing docetaxel in order to select the best one for animal experiments and clinical applications. Method Liposomes containing docetaxel were prepared using emulsifying-volatilizing technology, and composition of SPC-EPA-SCS-DOC (n : n : n : n = 7:1.8:1.2:1) was demonstrated to be the most effective. The physico-chemical properties of the liposomes were characterized. Result The prepared liposomes were small in size and welldistributed. The average size and entrapment efficiency were(110 ± 10)nm and above 95% ,respectively. It can be used for intravenous injection. Conclusion A simple, reliable method was established for liposomes containing docetaxel preparation.
出处 《中国药剂学杂志(网络版)》 2009年第1期1-5,共5页 Chinese Journal of Pharmaceutics:Online Edition
关键词 药剂学 脂质体 乳化挥散 多西他赛 理化性质 pharmaceutics liposome emulsifying-volatilizing docetaxel physico-chemical property
  • 相关文献

参考文献7

二级参考文献63

  • 1姜日花,李玉林,孙晶,增澤干男.多西他赛与依托泊苷抑制血管肉瘤细胞株ISOS- 1增殖的对比研究(英文)[J].中国新药与临床杂志,2005,24(3):169-173. 被引量:6
  • 2高勇,石昭泉,曹传武,朱长力,郭静.泰索帝联合顺铂及健择联合顺铂治疗非小细胞肺癌随机对照临床研究[J].癌症,2005,24(8):985-989. 被引量:19
  • 3Kim SC, Kim DW, Shim YH, et al. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy[J]. J Control Release, 2001, 72(1-3):191-202.
  • 4Campbell RB, Balasubramanian SV, Straubinger RM. Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes[J]. J Pharm Sci, 2001, 90(8):1091-1105.
  • 5Dordunoo SK, Jackson JK, Arsenault LA, et al. Taxol encapsulation in poly(epsilon-caprolactone)microspheres[J].Cancer Chemother Pharmacol, 1995, 36(4):279-182.
  • 6Mu L, Feng SS. Fabrication, characterization, and in vitro release of paclitaxel (Taxol)loaded poly(lactic-co-glycolic acid)microspheres prepared by spray drying technique with lipid/cholesterol[J]. J Control Release, 2001, 76(3):239 - 254.
  • 7Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol)[J]. J Control Release, 2002, 80(1-3):129-144.
  • 8Kim SY, Lee YM. Taxol-loaded block copolymer nanospheres compsed of methoxy poly(ethylene glycol)and poly (epsilon-caprolactone)as novel anticancer drug carriers [J]. Biomaterials, 2001, 22(13):1697-1704.
  • 9Cavalli R, Caputo O, Casco MR. Preparation and characterization of solid lipid nanospheres containing paclitaxel [J]. Eur J Pharm Sci , 2000, 10(4):305-309.
  • 10Fromes Y, Gounon P, Veitia R, et al. Influence of microtubule-associated proteins on the differential effects of paclitaxelanddocetaxel[J]. JProtein Chem, 1996, 15(4):377-388.

共引文献115

同被引文献9

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部